115 related articles for article (PubMed ID: 17284379)
1. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Frank SJ; Grimm PD; Sylvester JE; Merrick GS; Davis BJ; Zietman A; Moran BJ; Beyer DC; Roach M; Clarke DH; Stock RG; Robert Lee W; Michalski JM; Wallner KE; Hurwitz M; Potters L; Kuban DA; Prestidge BR; Vera R; Hathaway S; Blasko JC
Brachytherapy; 2007; 6(1):2-8. PubMed ID: 17284379
[TBL] [Abstract][Full Text] [Related]
2. Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation.
Spalding AC; Daignault S; Sandler HM; Shah RB; Pan CC; Ray ME
Urology; 2007 May; 69(5):936-40. PubMed ID: 17482938
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.
Torres-Roca JF; Cantor AB; Shukla S; Montejo ME; Friedland J; Seigne JD; Heysek R; Pow-Sang J
Urol Oncol; 2006; 24(5):384-90. PubMed ID: 16962486
[TBL] [Abstract][Full Text] [Related]
5. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
6. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
Beard C; Schultz D; Loffredo M; Cote K; Renshaw AA; Hurwitz MD; D'Amico AV
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):403-7. PubMed ID: 16765530
[TBL] [Abstract][Full Text] [Related]
7. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Dattoli M; Wallner K; True L; Cash J; Sorace R
Cancer; 2007 Aug; 110(3):551-5. PubMed ID: 17577217
[TBL] [Abstract][Full Text] [Related]
9. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Dattoli M; Wallner K; True L; Cash J; Sorace R
Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
[TBL] [Abstract][Full Text] [Related]
10. Patterns of local failure following prostate brachytherapy.
Stone NN; Stock RG; White I; Unger P
J Urol; 2007 May; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
[TBL] [Abstract][Full Text] [Related]
12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
13. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
[TBL] [Abstract][Full Text] [Related]
14. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States.
Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
Anticancer Res; 2006; 26(1B):575-80. PubMed ID: 16739323
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
[TBL] [Abstract][Full Text] [Related]
16. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
Nurani R; Wallner K; Merrick G; Virgin J; Orio P; True LD
J Urol; 2007 Nov; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
[TBL] [Abstract][Full Text] [Related]
17. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
[TBL] [Abstract][Full Text] [Related]
18. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
[TBL] [Abstract][Full Text] [Related]
19. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
[TBL] [Abstract][Full Text] [Related]
20. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Fang LC; Dattoli M; Taira A; True L; Sorace R; Wallner K
Urology; 2008 Jan; 71(1):146-50. PubMed ID: 18242384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
